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Purpose/Objective: Lung cancer patients experience changes of the 
lung tissue density due to atelectasis, pleural effusion or 
pneumonia/pneumonitis. Changes may be an indication for adaptation 
of the treatment plan in order to preserve sufficient target coverage. 
This study investigates when and for how many patients adaptation is 
needed due to these kinds of changes. 
Materials and Methods: We have analysed 165 lung cancer patients 
(Small Cell and Non-Small Cell) with daily cone-beam CT (CBCT). The 
CBCT scans were reviewed to find all patients with atelectasis, pleural 
effusion, pneumonia/ pneumonitis. For all patients we looked for the 
fraction number, when the change appeared and disappeared, the 
measurable size of the change and the consequences for the dose 
distribution. In addition it was estimated if the lung change gave rise 
to a shift of the tumour leading to a geometric miss. 
Results: 43 patients (26%) of the 165 lung cancer patients investigated 
had changes in their lung. 24 (15%) experienced atelectasis, 19 (12% ) 
pleura effusion and 8 (5%) had pneumonia/pneumonitis visible on 
CBCT. Only major density changes had consequences for the dose 
distribution, and we found that 7 % need an adaptive treatment plan, 
when we accept 1% change in the mean dose to PTV (Planning target 
volume) and under dosage of 3% of the PTV.  
In 42% of the atelectasis cases (6% of all patients) an appearing or 
disappearing atelectasis introduced a shift of the tumour larger than 5 
mm and hence a risk of geometric miss with consequences for the 
dose distribution.  
With respect to time of appearance and disappearance there is no 
system for pneumonia/pneumonitis and pleural effusion. For the 
atelectasis the time of appearance and disappearance is shown in fig. 
1. Half of the atelectasis cases are present at CT, while the other half 
appears during treatment. Only three patients have an atelectasis at 
CT that does not disappear at some point during the treatment. 
 
 
Fig. 1: Appearance and disappearance of atelectasis in 24patients. For 
each patient the grey bar shows the time interval with atelectasis 
present. Fraction 0 represents the planning CT-scan. 
Conclusions: For the 165 patients reviewed on CBCT an adaptive plan 
is necessary to assure a correct target coverage either due to changes 
in lung density in 12 patients (7%) or due to shift of the tumour 
because of the anatomical changes in 10 patients (6%). In total this 
corresponds to 12 % of the patients being candidates for an adaptive 
treatment plan as a few patients are present in both groups. We do 
not find a clear system in the time of appearance nor disappearance 
of the changes,and we therefore recommend that an adaptive 
strategy is based on population based criteria, but evaluated on the 
individual patient by the RTT on a daily basis.  
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Purpose/Objective: Differential motion between the tumor, involved 
lymph nodes and surrounding anatomy is frequently observed in 
locally advanced lung cancer patients treated with radiotherapy (RT). 
Perfect alignment can then not be achieved with an image guided 
couch correction but adaptive radiotherapy has the potential to 
improve the accuracy. Rather than making a new planning CT 
(possibly introducing new systematic errors) we propose to generate a 
CT scan on which the new plan can be made, based on the average 
anatomy of the patient as captured in the Cone Beam CTs (CBCTs) 
made over multiple fractions. 
Materials and Methods: A group of 25 patients was selected with 
locally advanced lung cancer treated with radical RT. These patients 
had a gold marker implanted in a mediastinal lymph node prior to 
making the planning CT scan. Using a rigid registration of the carina, 
tumor and the implanted marker we determined the relative shift of 
lymph node and tumor with respect to the carina. An automated 
decision rule was used to determine which patients had a systematic 
baseline shift of the tumor with respect to the carina large enough 
that a new planning could be beneficial, and at which fraction the 
replanning process should be started. Five patients were thus 
selected. 
For these patients the planning CT scan was deformably registered 
(multi resolution b-spline model combined with a smoothness penalty 
term) to the CBCTs made during the previous 6 fractions. The inverse 
average deformation field was applied to the original planning CT to 
obtain the average patient model. 
To validate this model, the generated CT scan was rigidly registered 
to the underlying CBCTs. If the generated CT is a good model of the 
patient anatomy, these rigid registrations should reduce the 
systematic baseline shift of the tumor and lymph nodes with respect 
to the carina. 
Results: The figure shows the planning CT scan (a) of one patient with 
delineated tumor, the CBCT (b) where the baseline shift of the tumor 
is apparent, and the generated CT (c) which accommodates the 
baseline shift. 
Table 1 shows in the first column of each patient the average baseline 
shift (in all three directions combined) over 6 fractions as seen in the 
CBCTs relative to the planning CT for both tumor and lymph node 
marker. The second column of each patient shows the average 
baseline shift with respect to generated average CT. This table shows 
a reduction in systematicbaseline shift for the tumor for all patients. 
The lymph node positions are less well modeled, as they are hidden 
inside the mediastinum. 
 
 
  
Conclusions: The average patient model based on deformable 
registration of the planning CT to CBCTs acquired prior to treatment is 
capable of reducing the systematic baseline shift of the tumor with 
respect to the carina. Further improvement in the deformable 
